Literature DB >> 861116

Suxamethonium-neostigmine interaction in patients with normal or atypical cholinesterase.

A Baraka.   

Abstract

The effect of neostigmine 0.05 mg/kg on the neuromuscular block produced by suxamethonium was investigated in 10 normal patients and in five patients with atypical plasma cholinesterase activity, by recording the twitch response to ulnar nerve stimulation. In the normal patients, neostigmine potentiated the block produced by suxamethonium whether it was of the depolarizing or desensitizing type. On the other hand, in patients with atypical plasma cholinesterase activity, neostigmine potentiated the depolarizing phase of suxamethonium block, while antagonizing the desensitizing phase. The degree of antagonism was not related to the magnitude of neuromuscular block, but was proportional to the degree of desensitization at the time of antagonism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861116     DOI: 10.1093/bja/49.5.479

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  5 in total

Review 1.  Anaesthesia and myasthenia gravis.

Authors:  A Baraka
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

Review 2.  A guide to drug interactions in anaesthetic practice.

Authors:  A W Grogono; J L Seltzer
Journal:  Drugs       Date:  1980-04       Impact factor: 9.546

Review 3.  Sugammadex: a review of its use in anaesthetic practice.

Authors:  Lily P H Yang; Susan J Keam
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Succinylcholine apnoea: attempted reversal with anticholinesterases.

Authors:  D R Bevan; F Donati
Journal:  Can Anaesth Soc J       Date:  1983-09

5.  Neostigmine antagonism of succinylcholine phase II block: a comparison with pancuronium.

Authors:  M E Futter; F Donati; A S Sadikot; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1983-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.